Dr. Gerald Diaz @GeraldMD
23.3M 13.8K 7.2K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief πŸ‡΅πŸ‡­ πŸ‡ΊπŸ‡Έ - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
7 results
Status Epilepticus - Management
Seizure > 5 mins or two seizures without complete recovery between them
PEDS
Benzo Dose
Status Epilepticus ... - Management Seizure ... β†’ Benzo Dose 2 ... algorithm #peds #pediatrics ... #neurology
Wernicke Encephalopathy - Acute B1 (Thiamine) Deficiency - Diagnosis and Management
Diagnosis - Caine Criteria (2 of
and Management ... Criteria (2 of ... Changes in mental status ... Any risk factor ... #Management #neurology
Hyponatremia - Diagnosis and Treatment
Hyponatremia is usually caused by the inability to excrete water normally.
Hyponatremia - Diagnosis ... 2) Is ADH elevated ... puts patients at risk ... #Treatment #management ... #nephrology #sodium
Management of Convulsive Status Epilepticus in children
Stabilization Phase (Seizure 0-5 minutes):
 β€’ Check and maintain ABC
Management of Convulsive ... mg) slowly over 2- ... mg) slowly over 2- ... Epilepticus #seizure #Management ... #neurology #pediatrics
Cabrini Respiratory Strain Score (CAB-RSS) - Respiratory Distress in COVID19

Respiratory rate (0-4)
Retraction/accessory muscle use (0-3)
Overall state
(0-3) Overall state ... 3) Total: 0–2, ... CABRSS #Distress #Risk ... #COVID19 #Diagnosis ... #Management #Intubation
Hypernatremia - Differential Diagnosis and Treatment
Hypernatremia is almost always due to unreplaced water loss (free water
, Dehydration: neurologic ... water unavailable 2) ... puts patients at risk ... #Treatment #management ... #nephrology #sodium
Babesiosis - Diagnosis and Management Summary 
Disease: Release of merozoites from erythrocytes and associated loss of
and Management ... Asymptomatic - Mostly in pediatric ... usually detected 2 ... Immunocompromised Patient with risk ... 10 days) up to 2